Description

GDF-8 95% – Myostatin Research Protein

GDF-8 95%, also known as Growth Differentiation Factor 8 or myostatin, is a research protein associated with scientific investigations into skeletal muscle regulation, cellular differentiation and transforming growth factor-beta (TGF-β) signalling.

Myostatin is a naturally occurring signalling protein encoded by the MSTN gene. It belongs to the TGF-β superfamily and plays an important role in regulating skeletal muscle development and growth.

GDF-8 is particularly relevant to muscle biology research because it acts as a negative regulator of skeletal muscle mass. Researchers investigate its molecular activity to understand the signalling pathways that control muscle development, myoblast differentiation and tissue maintenance.

This GDF-8 95% product description provides an overview of myostatin structure, biological function, receptor signalling, scientific research applications and laboratory quality considerations.

What Is GDF-8 (Myostatin)?

Growth Differentiation Factor 8, commonly called myostatin, is a protein involved in the regulation of skeletal muscle growth.

Myostatin was identified in scientific research as a member of the TGF-β superfamily that restricts skeletal muscle development.

Its biological role has been investigated extensively in genetic models, cell cultures and experimental animal studies.

Research involving reduced myostatin activity has demonstrated that disruption of this signalling pathway can produce substantial changes in muscle development in certain species.

However, these findings should not be confused with the effects of supplying active GDF-8 protein. Myostatin itself normally contributes to muscle growth restraint rather than stimulating muscle growth.

GDF-8 95% Product Specifications

• Product Name: GDF-8 95%
• Full Name: Growth Differentiation Factor 8
• Alternative Name: Myostatin
• Gene Symbol: MSTN
• Protein Family: Transforming Growth Factor-Beta (TGF-β) Superfamily
• Research Classification: Muscle growth regulatory protein
• Reference Human Precursor: 375 amino acids
• Reference Mature Protein: 109 amino acids per chain
• Biologically Active Structure: Disulfide-linked homodimer
• Approximate Mature Monomer Molecular Weight: 12.4 kDa
• Approximate Mature Dimer Molecular Weight: 25 kDa
• Primary Receptor Interactions: Activin type II receptors, including ActRIIB
• Associated Signalling Pathway: SMAD2/3
• Stated Purity: 95% – requires batch-specific verification
• Quantity: Confirm with manufacturer
• Molecular Form: Confirm whether mature GDF-8, precursor, propeptide or another construct
• Storage: Follow verified manufacturer instructions
• Intended Use: Laboratory research

The reference molecular weights above describe mature human myostatin. Recombinant protein constructs, propeptides, fusion proteins and modified forms may have substantially different molecular weights.

Understanding the Molecular Structure of GDF-8

Human myostatin is initially synthesised as a larger precursor protein containing 375 amino acid residues.

This precursor undergoes processing to produce a mature signalling domain.

The mature domain contains 109 amino acids and can form a disulfide-linked homodimer consisting of two protein chains.

The dimeric structure is important for biological activity and receptor interactions.

Myostatin can also exist in a latent complex in which the mature growth factor remains associated with its propeptide.

The latent complex has different biological properties from the fully active mature growth factor.

For accurate laboratory research, it is essential to distinguish between mature GDF-8, latent myostatin, GDF-8 propeptide and engineered recombinant constructs.

How Does GDF-8 Work?

GDF-8 regulates muscle biology through receptor-mediated cellular signalling.

Active myostatin can bind to activin type II receptors, particularly activin receptor type IIB (ActRIIB).

Receptor activation involves additional type I receptor components and downstream signalling through SMAD2 and SMAD3 proteins.

These signalling pathways influence the expression of genes associated with muscle cell differentiation, growth and tissue regulation.

Through these mechanisms, myostatin contributes to the restriction of excessive skeletal muscle growth.

The biological effects depend on receptor availability, protein activation state, tissue context and interactions with other signalling molecules.

Scientific Research Into GDF-8

1. Skeletal Muscle Growth Regulation

GDF-8 is extensively studied for its role in controlling skeletal muscle development.

Research involving genetic disruption of the MSTN gene has demonstrated pronounced increases in muscle mass in certain animal models.

These findings helped establish myostatin as an important negative regulator of muscle growth.

Scientists continue to investigate how myostatin activity interacts with other biological pathways involved in muscle maintenance.

However, reducing myostatin signalling and supplying active GDF-8 are fundamentally different experimental interventions.

2. Myoblast Differentiation Research

Myoblasts are precursor cells involved in the development of skeletal muscle fibres.

Their differentiation is regulated by multiple growth factors, transcription factors and signalling pathways.

GDF-8 has been investigated for its ability to influence myoblast proliferation and differentiation in experimental systems.

Research into these effects contributes to the understanding of skeletal muscle formation and the molecular regulation of muscle cell development.

The direction and magnitude of observed effects depend on the experimental model and the biological activity of the protein preparation.

3. SMAD2/3 Signalling Research

SMAD proteins are intracellular signalling molecules that transmit information from receptors to the nucleus.

GDF-8 activates pathways involving SMAD2 and SMAD3.

These pathways influence gene expression and cellular processes associated with muscle growth regulation.

Researchers use myostatin-related models to investigate how changes in receptor activation affect downstream signalling.

Understanding these pathways is important for basic research into muscle biology and TGF-β family signalling.

4. Myostatin Inhibition Research

Myostatin inhibition is an important area of experimental muscle biology.

Researchers have investigated antibodies, receptor traps and other compounds designed to reduce or block GDF-8 signalling.

Such studies aim to determine whether altering myostatin activity can influence muscle mass or function in selected disease models.

GDF-8 protein itself may be used as a reference ligand in laboratory experiments evaluating potential inhibitors.

However, results involving myostatin inhibitors must not be attributed to GDF-8 itself.

5. Muscle Wasting and Atrophy Research

Muscle atrophy refers to the reduction of muscle tissue that may occur during inactivity, ageing or certain medical conditions.

Myostatin signalling has been investigated in relation to muscle wasting and changes in skeletal muscle homeostasis.

Researchers examine how GDF-8 interacts with other regulatory systems involved in protein synthesis, degradation and tissue maintenance.

These investigations contribute to understanding the biological complexity of muscle loss.

They do not establish that a commercially supplied GDF-8 research protein is a treatment for muscle wasting.

6. Age-Related Muscle Biology

Age-related changes in skeletal muscle involve multiple biological processes, including altered cellular signalling and tissue regeneration.

Myostatin is one of several molecules studied in this field.

Researchers investigate whether changes in myostatin signalling contribute to differences in muscle mass and function across the lifespan.

However, age-related muscle changes cannot be explained by GDF-8 activity alone.

Further research is needed to determine the significance of different signalling pathways in human ageing.

7. Receptor Binding and Protein Interaction Research

GDF-8 has been studied for its interactions with activin receptors and other proteins that regulate its availability and biological activity.

Laboratory methods may be used to investigate receptor binding, protein structure and downstream signalling.

These studies contribute to the understanding of how growth factors communicate with cells.

Because different recombinant forms may exhibit different activity, researchers should verify whether a supplied GDF-8 preparation is biologically active.

GDF-8 vs GDF-11: What Is the Difference?

GDF-8 and GDF-11 are closely related proteins belonging to the TGF-β superfamily.

• GDF-8: Commonly known as myostatin and strongly associated with skeletal muscle growth regulation.
• GDF-11: A related growth differentiation factor involved in developmental and tissue biology.
• Structural Similarity: The mature proteins share substantial amino acid sequence similarity.
• Receptor Signalling: Both can interact with activin-related receptor pathways.
• Research Interpretation: Their biological activities overlap in some experimental contexts but are not identical.

Because of their structural similarity, laboratory methods should be selected carefully when distinguishing GDF-8 from GDF-11.

GDF-8 vs ACE-031: What Is the Difference?

GDF-8 and ACE-031 are different research molecules with distinct biological roles.

GDF-8 is the myostatin protein itself and normally contributes to restricting skeletal muscle growth.

ACE-031, as investigated in clinical research, is an engineered activin receptor type IIB fusion protein designed to bind selected signalling ligands, including myostatin.

Its mechanism involves reducing the availability of certain ligands for receptor activation.

These two research materials should not be confused because one is a signalling ligand and the other is a ligand-binding construct.

GDF-8 and Muscle Development: What Does the Evidence Show?

Myostatin is an established regulator of skeletal muscle growth in experimental biology.

Genetic and laboratory studies have demonstrated that reduced myostatin signalling can be associated with increased muscle development in selected models.

However, this does not mean that GDF-8 protein itself increases muscle mass.

Active GDF-8 generally contributes to muscle growth restraint.

Commercial claims describing GDF-8 as a proven muscle-building peptide are therefore scientifically misleading.

GDF-8 and Weight Management Research

GDF-8 is associated with research into body composition and metabolic regulation because skeletal muscle plays an important role in energy metabolism.

Experimental studies have examined relationships between myostatin signalling, muscle mass and metabolic characteristics.

However, GDF-8 is not an established weight-loss treatment.

There is insufficient clinical evidence to support claims that supplying GDF-8 produces reliable fat loss, improves body composition or treats obesity in humans.

Understanding the GDF-8 95% Label

The 95% designation is presented as a product specification and may refer to the manufacturer’s stated protein purity.

However, purity must be verified using batch-specific analytical documentation.

Different analytical methods may produce different purity measurements, and purity alone does not establish molecular identity or biological activity.

Researchers should confirm the supplied protein’s exact molecular form, purity testing method and batch-specific results before use.

GDF-8 Research Quality and Product Documentation

Important considerations when evaluating GDF-8 research material include:

• Verification of the exact recombinant protein identity
• Confirmation of species origin
• Identification of mature, precursor or propeptide form
• Confirmation of any affinity tags or fusion domains
• Batch-specific certificate of analysis
• Analytical purity testing using an appropriate method
• Protein identity verification
• Assessment of monomeric and dimeric forms
• Biological activity testing where relevant
• Accurate labelled protein quantity
• Manufacturer and batch traceability
• Information about formulation components
• Verified packaging and storage specifications
• Clearly stated intended-use restrictions

These details are particularly important because different forms of GDF-8 can have substantially different molecular and biological properties.

Storage and Handling of GDF-8

GDF-8 research protein should be stored according to verified manufacturer instructions.

Appropriate conditions depend on the protein’s molecular form, formulation, packaging and stability characteristics.

Researchers should not assume that every GDF-8 preparation has identical storage requirements.

Protein handling should follow the relevant laboratory safety documentation and institutional procedures.

GDF-8 Safety and Research Limitations

GDF-8 is a biologically active signalling protein involved in the regulation of skeletal muscle growth.

Its effects depend on molecular form, receptor interactions and experimental conditions.

Research-grade GDF-8 must not be assumed suitable for human administration.

There is no established clinical basis for using GDF-8 research protein as a weight-loss treatment, muscle-building product or general health supplement.

Commercial research material should not be represented as an approved medicine or a substitute for regulated clinical products.

This information is intended for scientific and educational purposes only and does not provide medical advice, human dosing recommendations or administration instructions.

Frequently Asked Questions About GDF-8 95%

What is GDF-8 95%?

GDF-8 95% is a product listing for Growth Differentiation Factor 8, also known as myostatin, with a stated 95% specification requiring batch verification.

What does GDF-8 stand for?

GDF-8 stands for Growth Differentiation Factor 8.

Is GDF-8 the same as myostatin?

Yes. GDF-8 is commonly known as myostatin.

What is GDF-8 researched for?

GDF-8 is studied in skeletal muscle biology, myoblast differentiation, receptor signalling and experimental muscle growth regulation.

Does GDF-8 increase muscle growth?

No. Active GDF-8 normally functions as a negative regulator of skeletal muscle growth.

What is the molecular weight of GDF-8?

Mature human GDF-8 has an approximate monomer mass of 12.4 kDa and forms a dimer of approximately 25 kDa. Other constructs may differ.

Is GDF-8 the same as GDF-11?

No. GDF-8 and GDF-11 are related but distinct proteins.

What does 95% mean in GDF-8 95%?

The percentage may represent a stated purity specification, but the actual purity and analytical method require verification against the relevant batch certificate.

Is GDF-8 a weight-loss peptide?

No. GDF-8 is not an established weight-loss treatment.

Is GDF-8 approved for medical use?

Research-grade GDF-8 is not an established approved medicine for muscle growth, weight management or other medical applications.

GDF-8 95% – Product Summary

GDF-8 95%, also known as myostatin, is a research protein associated with scientific investigations into skeletal muscle regulation, cellular differentiation and TGF-β signalling.

Its role as a negative regulator of muscle growth makes it an important molecular target in experimental muscle biology.

Researchers should distinguish active myostatin from myostatin inhibitors and confirm the exact molecular form, purity, biological activity and batch documentation before selecting GDF-8 for laboratory investigation.